News > India Likely to Approve 2-Dose Regimen for Covid-19 Vaccines, Four Weeks Apart

India Likely to Approve 2-Dose Regimen for Covid-19 Vaccines, Four Weeks Apart

India's drugs regulator is likely to approve administering two doses of the AstraZeneca-Oxford vaccine and another locally developed one by Bharat Biotech, each four weeks apart.

Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency's chief at a news conference scheduled on Sunday.